On August 28, 2018 Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, reported that the Company will present at the Baird 2018 Global Healthcare Conference on Wednesday, September 5 at 2:35-3:05 PM in Session III – Empire Ballroom B, Mezzanine Level of the InterContinental New York Barclay in New York (Press release, Curis, AUG 28, 2018, View Source [SID1234529101]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The presentation will be held using a fireside-chat format in which Ali Fattaey, Ph.D. President and Chief Executive Officer, will provide a brief overview of the Company’s pipeline of drug candidates and business strategy, after which an equity analyst will moderate a question and answer session.
A live webcast of the presentation will be available by visiting the investors section of Curis’ website View Source
A replay of the webcast will be archived on the website for 30 days following the presentation.